MindMed (OTCQB:MMEDF) released its full-year 2020 financial results.
The company posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the reporting period were $85.6 million, counting $80.1 million in cash.
The company used $24.2 million of net cash in operating activities in 2020.
Its cash balance as of Tuesday last week hovered at $161 million. The company plans to use the money to improve its portfolio and develop its technology sector.
On Monday, MindMed also revealed the results of a study on personalized MDMA dosing, conducted in conjunction with the Liechti Lab at the University Hospital Basel, in Switzerland.
Debut Diamonds Inc : Debut Diamonds Issues News Release Supplementing Management Information Circular finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Debut Diamonds Inc.: Debut Diamonds Announces Changes in Board of Directors
Debut Diamonds Inc. ( Debut Diamonds or the Company ) is announcing that the Company has appointed Yazeed Esnan to the current board of directors, effective as of the date hereof.
Mr. Yazeed Esnan has been an associate at First Republic Capital Corp., since graduating from Dalhousie University with a Bachelor of Commerce in Finance in 2017. In this time, he has acquired ample experience in equity financings and RTO transactions to take companies public. Mr. Esnan also previously worked with several private and public companies through the Cooperative Education program at Dalhousie University.
Debut Diamonds Inc.: Debut Diamonds Announces Reverse Takeover Transaction with Wesana Health and Brokered Financing Led by Stifel GMP
(CSE: DDI) (
Agreement ) dated February 2, 2021 with WeSana Health Inc. (
Wesana Health ) to complete a business combination by way of a transaction that will constitute a reverse takeover of the Company by Wesana Health (the
Transaction ). If completed, the Transaction will constitute a fundamental change of Debut Diamonds pursuant to the policies of the Canadian Securities Exchange (the
CSE ).
The Transaction will be structured as an amalgamation, arrangement, takeover bid, share purchase or other similar form of transaction or a series of transactions that have a similar effect with the Company acquiring all shares of Wesana Health. The final structure of the Transaction will be determined by the parties following receipt of tax, corporate and securities law advice. The Transaction is an arm s length transaction. The resulting issuer